Editas Medicine Inc
NASDAQ:EDIT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Editas Medicine Inc
NASDAQ:EDIT
|
US |
|
SalMar ASA
OSE:SALM
|
NO |
|
S
|
Suncast Solar Energy Inc
OTC:SUNC
|
US |
|
First Savings Financial Group Inc
NASDAQ:FSFG
|
US |
|
V
|
Viet Nam Power Development JSC
VN:VPD
|
VN |
|
ERG SpA
MIL:ERG
|
IT |
|
Delta Electronics Thailand PCL
SET:DELTA
|
TH |
|
T
|
Tanachira Retail Corporation Co Ltd
SET:TAN
|
TH |
|
AllDigital Holdings Inc
OTC:ADGL
|
US |
|
EFG Hermes Holdings SAE
LSE:EFGD
|
EG |
|
X
|
Xspring Capital PCL
SET:XPG
|
TH |
|
N
|
Nforce Secure PCL
SET:SECURE
|
TH |
|
Microbix Biosystems Inc
TSX:MBX
|
CA |
|
A
|
Axis Auto Finance Inc
XTSX:AXIS
|
CA |
|
K
|
Kalium Lakes Ltd
ASX:KLL
|
AU |
|
Indonesia Kendaraan Terminal Tbk PT
IDX:IPCC
|
ID |
|
B
|
Bualuang Office Leasehold Real Estate Investment Trust
SET:B-WORK
|
TH |
|
IGEA Pharma NV
SIX:IGPH
|
NL |
|
A
|
Anglo-Eastern Plantations PLC
LSE:AEP
|
UK |
|
P
|
Praram 9 Hospital PCL
SET:PR9
|
TH |
|
K
|
KMPharmaceutical Co Ltd
KOSDAQ:225430
|
KR |
|
D
|
DoorDash Inc
NASDAQ:DASH
|
US |
Bankruptcy Probability
Editas Medicine Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Editas Medicine Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Editas Medicine Inc
NASDAQ:EDIT
|
460.6m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
467.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
240.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
182.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
138.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
85.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
54B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
81B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Editas Medicine Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Editas Medicine Inc has total debt of 48.2m USD. This includes both short-term (0 USD) and long-term (48.2m USD) debt.
You can find a full breakdown on its Balance Sheet.
